Lista de obras -

A Range of Cancers Is Associated with the rs6983267 Marker on Chromosome 8

A common nonsense mutation of the BLM gene and prostate cancer risk and survival

artículo científico publicado en 2013

A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland

artículo científico publicado en 2006

A genetic risk score to guide age-specific, personalized prostate cancer screening

A genetic risk score to personalize prostate cancer screening, applied to population data

scientific article published on 24 June 2020

A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer

artículo científico publicado en 2006

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

artículo científico publicado en 2014

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease

artículo científico publicado en 2012

A personalised approach to prostate cancer screening based on genotyping of risk founder alleles

artículo científico publicado en 2013

A six-nucleotide deletion in the CASP8 promoter is not associated with a susceptibility to breast and prostate cancers in the Polish population

artículo científico publicado en 2007

Allelic modification of breast cancer risk in women with an NBN mutation

scientific article published on 13 August 2019

An inherited NBN mutation is associated with poor prognosis prostate cancer

artículo científico publicado en 2012

Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation

artículo científico publicado en 2016

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

BARD1 is A Low/Moderate Breast Cancer Risk Gene: Evidence Based on An Association Study of the Central European p.Q564X Recurrent Mutation

artículo científico publicado en 2019

BRCA1 mutations and colorectal cancer in Poland.

artículo científico publicado en 2010

BRCA1 mutations and prostate cancer in Poland

artículo científico publicado en 2008

Breast cancer susceptibility genes

article

CHEK2 germline mutations correlate with recurrence rate in patients with superficial bladder cancer

scientific article published on 01 January 2008

CHEK2 mutations and HNPCC-related colorectal cancer.

artículo científico publicado en 2010

CHEK2 mutations and the risk of papillary thyroid cancer.

artículo científico publicado en 2015

CHEK2 mutations as markers for high risk of breast cancer

artículo científico publicado en 2012

CHEK2-positive breast cancers in young Polish women

scientific article published on 01 August 2006

Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis

artículo científico publicado en 2015

Common variants of DNA repair genes and malignant melanoma

artículo científico publicado en 2007

Common variants of xeroderma pigmentosum genes and prostate cancer risk

artículo científico publicado en 2014

Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers

artículo científico publicado en 2008

Corrigendum: Germline RECQL mutations are associated with breast cancer susceptibility

artículo científico publicado en 2016

DNA testing for high risk of prostate cancer

artículo científico publicado en 2012

DNA variation in MSR1, RNASEL and E-cadherin genes and prostate cancer in Poland

scientific article published on 01 January 2007

Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer

artículo científico publicado en 2011

Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations.

artículo científico publicado en 2008

Epistatic relationship between the cancer susceptibility genes CHEK2 and p27

scientific article published on 01 March 2007

Erratum: Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?

artículo científico publicado en 2007

Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention

artículo científico publicado en 2008

Exploring the link between germline and somatic genetic alterations in breast carcinogenesis

artículo científico publicado en 2010

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

artículo científico publicado en 2018

Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology

article

Genetic heterogeneity of 8q24 region in susceptibility to cancer.

artículo científico publicado en 2009

Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?

artículo científico publicado en 2006

Germline RECQL mutations are associated with breast cancer susceptibility

artículo científico publicado en 2015

Germline mutations in theCHEK2 kinase gene are associated with an increased risk of bladder cancer

artículo científico publicado en 2007

HLA-G polymorphism and in vitro fertilization failure in a Polish population

artículo científico publicado en 2009

HOXB13 mutations and prostate cancer in Poland.

artículo científico publicado en 2012

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

artículo científico publicado en 2013

Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk

artículo científico publicado en 2008

Inherited Variants in BLM and the Risk and Clinical Characteristics of Breast Cancer

artículo científico publicado en 2019

Inherited variants in XRCC2 and the risk of breast cancer

scientific article published on 28 August 2019

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

artículo científico publicado en 2019

Meeting abstracts from the Annual Conference on Hereditary Cancers 2016: Szczecin, Poland. 14-15 September 2016.

artículo científico publicado en 2017

Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans

artículo científico publicado en 2015

Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland

artículo científico publicado en 2020

Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland.

artículo científico publicado en 2014

NBS1 Mutation and prognosis of prostate cancer

PALB2 mutations and prostate cancer risk and survival

artículo científico publicado en 2021

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts

artículo científico publicado en 2018

Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe

artículo científico publicado en 2015

Progress in clinical genetics of prostate cancer

article

Prostate cancer screening based on genotyping for high risk founder alleles

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

artículo científico publicado en 2018

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.

artículo científico publicado en 2018

Recurrent PALB2 mutations and the risk of cancers of bladder or kidney in Polish population

artículo científico publicado en 2021

Recurrent mutations of BRCA1 and BRCA2 in Poland: an update

artículo científico publicado en 2014

Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer

artículo científico publicado en 2011

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study

artículo científico publicado en 2011

Smoking related cancers and loci at chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish population

artículo científico publicado en 2011

Survival from breast cancer in patients with CHEK2 mutations.

artículo científico publicado en 2014

Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk

artículo científico publicado en 2008

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study

artículo científico publicado en 2014

The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland

artículo científico publicado en 2013

The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer

artículo científico publicado en 2012

The effect of sample size on polygenic hazard models for prostate cancer

artículo científico publicado en 2020

The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations

artículo científico publicado en 2022

The presence of prostate cancer at biopsy is predicted by a number of genetic variants

artículo científico publicado en 2013

The risk of breast cancer in women with a CHEK2 mutation

artículo científico publicado en 2012

The risk of gastric cancer in carriers of CHEK2 mutations

artículo científico publicado en 2013

The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish population.

artículo científico publicado en 2010

The spectrum of mutations predisposing to familial breast cancer in Poland

scientific article published on 26 June 2019

The variant allele of the rs188140481 polymorphism confers a moderate increase in the risk of prostate cancer in Polish men

artículo científico publicado en 2015

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

artículo científico publicado en 2021

Lista de obras de

A Range of Cancers Is Associated with the rs6983267 Marker on Chromosome 8

A common nonsense mutation of the BLM gene and prostate cancer risk and survival

A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland

A genetic risk score to guide age-specific, personalized prostate cancer screening

A genetic risk score to personalize prostate cancer screening, applied to population data

A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease

A personalised approach to prostate cancer screening based on genotyping of risk founder alleles

A six-nucleotide deletion in the CASP8 promoter is not associated with a susceptibility to breast and prostate cancers in the Polish population

Allelic modification of breast cancer risk in women with an NBN mutation

An inherited NBN mutation is associated with poor prognosis prostate cancer

Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

BARD1 is A Low/Moderate Breast Cancer Risk Gene: Evidence Based on An Association Study of the Central European p.Q564X Recurrent Mutation

BRCA1 mutations and colorectal cancer in Poland.

BRCA1 mutations and prostate cancer in Poland

Breast cancer susceptibility genes

CHEK2 germline mutations correlate with recurrence rate in patients with superficial bladder cancer

CHEK2 mutations and HNPCC-related colorectal cancer.

CHEK2 mutations and the risk of papillary thyroid cancer.

CHEK2 mutations as markers for high risk of breast cancer

CHEK2-positive breast cancers in young Polish women

Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis

Common variants of DNA repair genes and malignant melanoma

Common variants of xeroderma pigmentosum genes and prostate cancer risk

Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers

Corrigendum: Germline RECQL mutations are associated with breast cancer susceptibility

DNA testing for high risk of prostate cancer

DNA variation in MSR1, RNASEL and E-cadherin genes and prostate cancer in Poland

Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer

Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations.

Epistatic relationship between the cancer susceptibility genes CHEK2 and p27

Erratum: Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?

Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention

Exploring the link between germline and somatic genetic alterations in breast carcinogenesis

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology

Genetic heterogeneity of 8q24 region in susceptibility to cancer.

Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?

Germline RECQL mutations are associated with breast cancer susceptibility

Germline mutations in theCHEK2 kinase gene are associated with an increased risk of bladder cancer

HLA-G polymorphism and in vitro fertilization failure in a Polish population

HOXB13 mutations and prostate cancer in Poland.

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk

Inherited Variants in BLM and the Risk and Clinical Characteristics of Breast Cancer

Inherited variants in XRCC2 and the risk of breast cancer

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

Meeting abstracts from the Annual Conference on Hereditary Cancers 2016: Szczecin, Poland. 14-15 September 2016.

Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans

Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland

Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland.

NBS1 Mutation and prognosis of prostate cancer

PALB2 mutations and prostate cancer risk and survival

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts

Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe

Progress in clinical genetics of prostate cancer

Prostate cancer screening based on genotyping for high risk founder alleles

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.

Recurrent PALB2 mutations and the risk of cancers of bladder or kidney in Polish population

Recurrent mutations of BRCA1 and BRCA2 in Poland: an update

Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study

Smoking related cancers and loci at chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish population

Survival from breast cancer in patients with CHEK2 mutations.

Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study

The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland

The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer

The effect of sample size on polygenic hazard models for prostate cancer

The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations

The presence of prostate cancer at biopsy is predicted by a number of genetic variants

The risk of breast cancer in women with a CHEK2 mutation

The risk of gastric cancer in carriers of CHEK2 mutations

The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish population.

The spectrum of mutations predisposing to familial breast cancer in Poland